The episode opens with a brief German radio-style advertisement for Rhön Sprudel mineral water, evoking the imagery of natural mountain landscapes before transitioning into the Solved podcast intro.

Mark Manson opens with a vivid metaphor — fighting a kitchen fire with water — to set up the central argument: most people are treating anxiety with things that feel easy rather than things that work. He lists all 17 interventions (adaptogens, alcohol, benzodiazepines, breathwork, CBD, digital detoxes, journaling, physical exercise, magnesium, meditation, probiotics, psychedelics, therapy, sleep, socializing, SSRIs, and yoga) and explains the four-category framework: Legitimately Works, Sort of Depends, Not Helping But Not Hurting, and Bullshit. The goal isn't just to rank interventions but to surface the surprising patterns and caveats that emerge when the research is taken seriously.

Drawing on the American Psychological Association's definition and evolutionary biology, Manson explains that anxiety differs from fear in a crucial way: fear is triggered by a present, specific threat (a lion charging), while anxiety is a diffuse cognitive state about potential future threats (wondering if a lion might be nearby). This future-orientation makes anxiety uniquely susceptible to cognitive interventions. The pair also discuss the genetic contribution (30–40% of anxiety is heritable), the role of the amygdala and prefrontal cortex, and why women and young people tend to be more anxious. Drew adds that anxiety can be understood as the collision between the brain's prediction drive and its negativity bias.

Drew Berti reads a mid-roll advertisement for Quicksilver Scientific's GLP-1 amplifier, which is marketed as supporting metabolic balance and reducing cravings. Listeners are directed to tryqs.com/podcast for 10% off and free shipping.

Manson argues for an existential root to modern anxiety, tracing it to Kierkegaard's 19th-century observation that increasing freedom and optionality paralyzes people rather than liberating them. He quotes José Martí — 'If the mind does not have a problem to work on, it will quickly invent some' — to argue that modern comfort and meaninglessness causes the brain to manufacture threats. Drew and Mark also discuss high-functioning anxiety, the misconception that the optimal level of anxiety is zero, and whether the mental health crisis is partly driven by people who have outsourced real problem-solving and replaced it with worry. The segment closes with Manson's spicy take: we are more anxious today not because the world got scarier, but because it got too safe.

In a brief personal interlude, Drew reveals he suffered panic attacks into his mid-twenties and that anxiety runs in his family, while Mark reflects that his own anxiety has been limited mostly to social situations rooted in childhood trauma. The conversation touches on the common fear that getting rid of anxiety will eliminate the drive to perform, and Mark introduces the idea that over-identifying with the label 'anxious person' calcifies the condition into a permanent identity.

Alcohol earns the sole spot in the 'Bullshit' category. While it provides genuine short-term relief through GABA enhancement, the rebound anxiogenic effect — colloquially known as 'hangxiety' — is strongest in exactly the people most likely to drink for anxiety relief: shy, socially anxious individuals. More dangerously, alcohol blocks fear extinction, the neurological loop that allows exposure therapy and real-world coping to work. Manson illustrates this with a story from his dating coach career: men who drank to manage approach anxiety never progressed, while sober men did. He also reveals that for heavy drinkers, quitting alcohol would rank #4 out of all 17 interventions — above meditation and most pharmaceuticals — a finding that surprises Drew.

Magnesium for anxiety has exploded on TikTok, but the research is all over the map: different forms, inconsistent studies, no proper control groups. Drew notes that if you're actually deficient, magnesium might restore a baseline, but it won't treat anxiety beyond that. A frequently cited 2021 study lacked a control group and was post-hoc, yet became the foundation of a massive marketing narrative. Manson explains the mechanics of UGC (user-generated content) marketing platforms, where supplement brands set per-view bounties for thousands of creators, synthetically generating what looks like organic grassroots trends — a practice he suspects is the real engine behind the magnesium craze, despite personally owning three large bottles himself.

Journaling ranks surprisingly low for anxiety specifically, even though it scored well on the previous self-improvement episode. The logic is intuitive: anxious people already overthink, and most forms of journaling — gratitude, freeform, venting, brain dumping — simply give the anxious mind more fuel. The one exception is a structured exposure-style journaling method (mapping worst-case scenarios and responses, similar to Stoic negative visualization) that has some evidence behind it, requiring 30 minutes a day for at least three days. The catch: in one online study, over half of participants quit before completing it. Manson adds a subtler critique — constantly labeling yourself as anxious in a journal hardens that identity, causing the brain to seek out confirming evidence and potentially preventing recovery.

CBD commands a $5 billion market, but the underlying science is nearly nonexistent for anxiety. Drew walks through a 2024 meta-analysis that screened 1,550 research papers and found only 8 met quality criteria, covering 316 people total. Even those 8 produced a confidence interval so wide that researchers concluded the effect size was 'either amazing or basically nothing.' Two additional problems compound the issue: some studies found that exactly 300mg is required (while commercial products offer 10–50mg), and a 2022 study found that barely half of 80 tested products actually contained their labeled CBD dose. Manson concludes it's likely placebo, and the pair discuss how it reached peak hype in the late 2010s before gradually fading.

Both hosts admit wanting this one to work more than it does. The research confirms that replacing digital habits with time in nature does meaningfully reduce anxiety in the moment, but the bounce-back upon returning to screens and news media is swift and complete. The segment settles on a nuanced verdict: a walk in the park after a rough Monday can take the edge off, but it won't treat panic disorder or address underlying anxiety patterns. Drew and Mark compare it to what people mistakenly think alcohol does — a way to decompress — without the hangxiety downside, but equally temporary.

Breathwork occupies a genuinely split verdict: the right technique at the right moment is highly effective; the wrong technique can be catastrophic. Drew describes how a 1:2 inhale-to-exhale ratio (e.g., 4-8 breathing) helped him manage the panic attacks he used to experience while driving. Manson adds context from when his wife Fernanda had a severe panic attack requiring paramedics — the EMT explained that panic-attack hyperventilation creates a feedback loop of under-oxygenation, and slowing the breath counterintuitively reverses it. However, Manson is deeply skeptical of long-session, cathartic breathwork seminars that promise to 'unlock childhood wounds.' He argues these hyperventilation sessions simply induce high-arousal emotional states, and for anxiety-prone people, that's exactly the opposite of what's needed. The real mechanism of box breathing, Drew suggests, is interoceptive redirection: turning attention inward and realizing the body is manageable.

Benzodiazepines (Xanax, Valium, Ativan, Klonopin) have decades of strong research behind them and genuinely powerful effect sizes — if not for their safety profile, they'd be a top-3 intervention. The complications are severe: physical dependence, potentially lethal withdrawal, high abuse rates, and the fact that they work on the same GABA system as alcohol, blocking the fear extinction loop that therapy relies on. Manson notes that buspirone, an equally effective alternative, is avoided by patients because it takes 2–4 weeks to kick in, while benzos work almost immediately — a preference that consistently drives over-reliance. Both hosts know people who have been on low-dose benzos for years despite medical recommendations capping use at 2–4 weeks.

Probiotics rank higher than many would expect, powered by a plausible mechanism: the vagus nerve connects gut and brain, GABA function in the brain is influenced by gut bacteria, and 90% of the body's serotonin is produced in the gut. Multiple studies find effect sizes of 0.5–0.7 for clinically diagnosed anxiety disorders, though the benefit is minimal for mild or subclinical anxiety. The major caveat is what one meta-analysis memorably called 'catastrophic heterogeneity' — the results and methodologies vary so wildly across studies that no coherent picture emerges on which strains work for which people. Drew predicts this area will become more powerful as personalized medicine develops the tools to match specific probiotic strains to specific individuals.

Drew, a regular hot yoga practitioner, offers a pragmatic take: yoga helps anxiety through interoception (awareness of internal bodily states) and by deliberately practicing the muscle of tolerating discomfort in awkward, vulnerable social situations. A clinical trial found roughly 50% of yoga participants responded positively compared to about 70% for therapy. Manson notes that yoga likely scores lower than exercise primarily due to lower intensity, and lower than meditation because it addresses the physical rather than cognitive dimension of anxiety. Drew sees hot yoga's added value in its socially vulnerable context — a room full of half-naked people in difficult poses forces you to abandon self-consciousness and return to bodily presence. Both agree yoga is a useful supplement, not a standalone solution.

Adaptogens — ashwagandha, rhodiola, holy basil — are now found in everything from energy drinks to mocktails, promising relaxation and stress relief. The early study results are surprisingly good with some strong effect sizes, but the research has the same problems as CBD and magnesium: small samples, variable methodologies, different product formulations, and frequent industry funding. Manson uses the segment to explain what distinguishes a good study (randomization, blinding, large and diverse samples, placebo controls) from a bad one. He admits to drinking ashwagandha mocktails at social events, though he suspects the calming effect is purely placebo from having been marketed that way. Drew urges caution while acknowledging a few small but well-designed studies do find real effects.

Antidepressants (Prozac, Zoloft, Lexapro) occupy a paradoxical position: the Cochrane Review confirms they work, yet recent meta-analyses spanning decades have failed to establish a reliable link between serotonin levels and depression or anxiety, effectively dismantling the 'chemical imbalance' theory. Effect sizes were large in early trials conducted on the most severe cases, but have moderated as prescription has expanded to milder presentations. Side effects — sexual dysfunction, emotional blunting — are common enough to drive many patients off medication. Manson draws a distinction between clinical anxiety (probably genetic, likely requires medical intervention) and subclinical anxiety (contextual, addressable through lifestyle), arguing SSRIs are probably life-changing for the former and likely overkill for the latter. He and Drew also discuss the broader labeling problem: therapy culture's tendency to diagnose everyone with clinical-level anxiety when most people simply have high neuroticism or stressful lives.

Psychedelics rank 6th despite having the largest single effect size on the entire list, largely because the research base is still thin and blinding is impossible — participants always know if they've taken a powerful psychedelic. Drew describes the landmark Roland Griffiths study at Johns Hopkins in which terminal cancer patients treated with psilocybin reported dramatic reductions in anxiety and described the experience as among the most meaningful of their lives. Manson explains the mechanism — psychedelics trigger neuroplasticity, opening a window of cognitive flexibility lasting 1–2 months in which identity and belief patterns can be more easily reshaped. He's anecdotally suspicious of chronic users, noting they tend to adopt the last thing they heard as a new philosophy. Both hosts stress the importance of professional guidance and structured settings, and acknowledge that the FDA's 2024 rejection of MDMA for PTSD reflects the fundamental difficulty of controlling for psychedelic effects in trials.

Socializing enters the 'Legitimately Works' tier at #5. The key finding is asymmetric: loneliness strongly predicts anxiety, but having a strong social network doesn't automatically prevent it — social connection functions as a protective buffer, not an active treatment. Most interestingly, research shows that merely believing you have people in your corner reduces anxiety more than actually calling on that support. Drew and Mark both admit to being bad at asking for help, but acknowledge that knowing the support exists provides genuine relief. The entry is complicated by the doom loop: people with anxiety, especially social anxiety, isolate themselves, which deepens their anxiety and drives further isolation. Both hosts reference their extensive prior research on loneliness and friendship as context for why this ranks so high.

Sleep earns its 4th-place ranking through a mechanism most people overlook: during REM sleep, the brain replays emotional memories with reduced amygdala activity, essentially performing anxiety therapy on itself every night. Skipping sleep doesn't just leave you tired — it robs you of this emotional processing, meaning every night of poor sleep compounds the next day's anxiety. The doom loop is brutal: anxiety causes insomnia, insomnia worsens anxiety. Mark speculates that the teen mental health crisis has been significantly worsened by widespread sleep deprivation from late-night phone use. He also notes that sleep is a prerequisite rather than an additive: without it, nothing else on the list — supplements, meditation, exercise — will function optimally. The intervention is free, universal, and available every day, which makes widespread sleep deprivation in the modern world all the more maddening.

Exercise's evidence base is simply overwhelming: the largest meta-analysis included over 1,000 high-quality RCTs with more than 128,000 participants showing consistent moderate effect sizes across ages, genders, nationalities, and backgrounds. Any moderate-to-high intensity activity for 20–45 minutes, 3–4 times per week works, and consistency matters far more than type. But the mechanism Manson finds most compelling is a frame he encountered in the research: every hard workout is practice for being afraid. Exercise places the body in exactly the physiological state of fear — elevated heart rate, shallow breathing, adrenaline — and every completed rep is a rehearsal for acting despite those signals. Drew adds that the consistency itself builds agency and discipline, which directly counters anxiety's core experience of helplessness. The 'tame the body, tame the mind' principle makes exercise not just a neurochemical intervention but a psychological one.

Meditation surprises Manson by ranking higher than exercise on the research. Drew explains the key: the strongest evidence comes from full MBSR (Mindfulness-Based Stress Reduction) protocols — structured 8-week programs developed by Jon Kabat-Zinn, involving multiple hours per week. Casual 5-minute sessions show little effect on anxiety specifically. The crucial distinction both hosts land on is that meditation doesn't reduce anxious thoughts — it changes your relationship to them. Where exercise provides faster, more perceptible short-term mood benefits, meditation delivers a slower but potentially deeper cognitive restructuring: the ability to observe thoughts without being controlled by them, to see the mind's patterns clearly, and to find the anxiety less threatening not because it's gone but because you've changed how you relate to it. They recommend the Waking Up app specifically for its philosophical depth and introduce a listener offer of 30 days free.

Mark and Drew offer a 30-day free trial of the Waking Up app, which they describe as superior to other meditation apps due to its emphasis on the philosophical nature of mind rather than quick relaxation. The introductory course is specifically recommended as a free starting point.

Therapy — particularly CBT and ACT — takes the top spot. CBT's 'durability advantage' is its defining feature in the research: patients maintain near post-treatment anxiety levels a full year after stopping, because the therapy teaches real-world skills that continue to develop after sessions end. Unlike medication, remission rates for CBT patients don't collapse when treatment stops. ACT approaches the same destination from the opposite direction — rather than challenging anxious thoughts (CBT), ACT teaches radical acceptance of them — and the fact that both methods work equally well tells Drew something profound about what anxiety actually requires: a relationship with uncertainty and agency within it, not control over outcomes. Manson adds a cultural critique: the therapy industry has a supply crisis (8–10 people per therapist) and quality varies enormously, but the biggest misunderstanding is that the point of therapy is eventually to stop — and leaving therapy often produces a second positive boost to outcomes.

The episode closes with both hosts reflecting on the pattern that emerged from the rankings: everything in the 'Legitimately Works' tier is a lifestyle change requiring long-term commitment, while everything outside that tier is a quick fix chosen for ease. Manson lands on a unifying thesis — chronic anxiety may fundamentally be an unwillingness to tolerate discomfort, and every effective treatment is some form of calibrated exposure to discomfort that gradually raises one's threshold. Drew's biggest surprise was that CBT and ACT — seemingly opposite philosophies — converge on the same destination, while Mark's was meditation ranking as high as it did. They close with plugs for solvedpodcast.com/anxiety (free downloadable materials), the Purpose AI coaching app (free 7-day trial), and a mutual encouragement to subscribe and review.